Dr. Ramon Schaefer is a health economist at the DKFZ, and was, until recently, affiliated with the Medical Faculty Mannheim of Heidelberg University. His primary research focuses on Health Technology Assessments (HTAs) conducted by national HTA agencies, with an emphasis on comparing evaluation outcomes and examining how these are influenced by methodological choices. In addition, he is currently involved in projects related to the measurement of social preferences for health care interventions and the economic concept of the value of (a statistical) life (year).
Since 2015, Dr. Schaefer has served as a research associate and scientific project manager at the independent Institute for Innovation & Valuation in Health Care (InnoVal-HC) in Wiesbaden.
Selected Publications:
M. Schlander, D. Hernandez, O. Schwarz, R. Schaefer:
Are commonly used cost-effectiveness thresholds too low? Empirical evidence from economic studies on the value of life.
International Journal of Technology Assessment in Health Care, 2025: 40(Suppl 1), S85.
DOI: 10.1017/S0266462324002435
R. Schaefer, D. Hernandez, T. Bärnighausen, P. Kolominsky-Rabas, M. Schlander:
Health technology assessment–informed decision making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England: The Role of Budget Impact.
Value in Health, 2023: 26(7), 1032-1044.
DOI: 10.1016/j.jval.2023.02.018
R. Schaefer, D. Hernandez, L. Selberg, M. Schlander:
Health technology assessment (HTA) in England, France and Germany: What do matched drug pairs tell us about recommendations by national HTA agencies?
Journal of Comparative Effectiveness Research, 2021: 10(16), 1187-1195.
DOI: 10.2217/cer-2021-0047